EISNER MARK (EVP and Chief Medical Officer) sold 1.3% of their position (2.09K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $15.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001628280-26-011329
Officer· EVP and Chief Medical Officer
Since Feb 2026
+162.91K
Net shares
Net buyer
$15.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
165K acquired · 2.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+55K
Price / share
—
Trade value
—
% of position
52.6%
2/22/2026
104.62K→159.62K
Common Stock
Direct
Shares
−2.09K
Price / share
$7.45
Trade value
$15.57K
% of position
1.3%
2/23/2026
159.62K→157.53K
Total
Net shares
+52.91K
Net value
-$15.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2026 | A · Award | +55K | — | — | 52.6% | 104.62K | 159.62K |
| Common Stock Direct | 2/23/2026 | S · Sale | −2.09K | $7.45 | $15.57K | 1.3% | 159.62K | 157.53K |
| Total | +52.91K | -$15.57K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
110K shares
Shares
+110K
Strike price
7.56
Held after
110K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock110K shares | 2/22/2026 | A · Award | +110K | 7.56 | — | 110K |